Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model
HIMS expands its connected care model with new diagnostics, hormonal health services and at-home testosterone treatments.
Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive' - Boise Cascade ( NYSE:BCC ) , Doximity ( NYSE:DOCS )
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended waiting before buying telehealth firm Doximity, Inc. ( NYSE:DOCS ) , noting it is "still too expensive." Doximity, on Nov. 6, reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 38 cents ...
Why Doximity ( DOCS ) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
This House of Representative Just Bought Up To $115K In Robinhood Markets Stock - Doximity ( NYSE:DOCS ) , Robinhood Markets ( NASDAQ:HOOD )
A November filing shows that Representative Jonathan Jackson reported a purchase in Robinhood Markets ( NASDAQ:HOOD ) , valued between $31,003 and $115,000. The transaction date is listed as October 8, 2025, with the report published on November 10, 2025.
Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release?
Tempus AI posts first positive adjusted EBITDA and 84.7% revenue surge, signaling new growth momentum amid premium valuation.
Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y
DOCS Q2 results benefit from the rise in AI-driven engagement. However, the stock plunges nearly 9% in pre-market trading.
Doximity ( DOCS ) Tops Q2 Earnings and Revenue Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +18.42% and +6.81%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
What the Options Market Tells Us About Doximity - Doximity ( NYSE:DOCS )
Investors with significant funds have taken a bearish position in Doximity ( NYSE:DOCS ) , a development that retail traders should be aware of. This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga.
AI Stocks Slide Again, Bitcoin Dips Near $100,000: Markets Today - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ )
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto markets.
Doximity ( DOCS ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Doximity (DOCS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Doximity ( DOCS ) Beat Estimates Again in Its Next Earnings Report?
Doximity (DOCS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Buy These 5 Health and Fitness Stocks for a Stable Portfolio in Q4
DOCS, PLNT, UNFI, PTON and PFGC are five health and fitness stocks with growth potential, diversified revenue and resilient demand.
ECL Stock Falls in Pre-Market Despite Q3 Earnings Beat, Margins Expand
Ecolab tops third-quarter 2025 estimates with strong margin gains and lifts full-year EPS outlook amid steady segment growth.
Doximity ( DOCS ) Surpasses Market Returns: Some Facts Worth Knowing
Doximity (DOCS) closed at $68.5 in the latest trading session, marking a +2.48% move from the prior day.
Hims & Hers Advances AI-Powered Personalized Digital Healthcare
HIMS accelerates AI-powered care with new tech leadership, personalized treatments and a major $870 million investment push.
Here's Why Doximity ( DOCS ) Fell More Than Broader Market
In the closing of the recent trading day, Doximity (DOCS) stood at $65.61, denoting a -9.59% move from the preceding trading day.
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Allogene Therapeutics ( NASDAQ:ALLO ) , Akero Therapeutics ( NASDAQ:AKRO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Andrew S.
Can Doximity's New AI Suite Drive the Growth It Needs?
DOCS reports stronger Q1 results and is betting on its new AI suite -- Scribe, GPT, and Pathway -- to drive its next growth phase.
Doximity ( DOCS ) Stock Sinks As Market Gains: What You Should Know
Doximity (DOCS) closed the most recent trading day at $70.64, moving 3.43% from the previous trading session.
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?
Hims & Hers and Doximity are transforming digital health, but which leads in earnings growth and platform expansion? Let's see.
Congressional Trading Report: Rep. Jonathan Jackson Bought Over $16K In Doximity Stock - Doximity ( NYSE:DOCS ) , ARM Holdings ( NASDAQ:ARM )
An official report on September 23, 2025 reveals Representative Jonathan Jackson's recent purchase of Doximity DOCS stock, valued between $16,002 and $65,000. The transaction took place on August 25, 2025, as per the September filing. At this time, Doximity shares are trading up 1.54% at $75.03.
Do Options Traders Know Something About Doximity Stock We Don't?
Investors need to pay close attention to DOCS stock based on the movements in the options market lately.
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation
HIMS is scaling globally with AI-powered care, new treatments and an $870 million boost to expand its digital ecosystem.
Doximity ( DOCS ) Exceeds Market Returns: Some Facts to Consider
Doximity (DOCS) closed at $73.6 in the latest trading session, marking a +1.28% move from the prior day.
Doximity ( DOCS ) Increases Despite Market Slip: Here's What You Need to Know
Doximity (DOCS) closed at $71.03 in the latest trading session, marking a +1.1% move from the prior day.
What's Driving the Market Sentiment Around Doximity? - Doximity ( NYSE:DOCS )
Doximity's DOCS short interest as a percent of float has risen 7.65% since its last report. According to exchange reported data, there are now 4.70 million shares sold short, which is 3.52% of all regular shares that are available for trading.
Phreesia PHR Q2 2026 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Sept. 4, 2025 at 5 p.m. ETChief Executive Officer - Chaim IndigContinue reading ...
HIMS' Personalized Wellness Platform Expands Preventive Care Access
Hims & Hers expands its personalized wellness platform, aiming to reshape preventive care through tech-driven, holistic solutions.
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Deal Dispatch: Performance Food Rejects Offer, Claire's Bankrupt - American Woodmark ( NASDAQ:AMWD ) , Boeing ( NYSE:BA )
Performance Food rejects offer; Bachan's, Hg and Yomeishu explore sales; Lufthansa drops Air Europa bid; NFL sells media to ESPN Skydance Media finally completed its $8-billion acquisition of Paramount Global. Sen. Warren called it a "wink, wink" arrangement.
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings - Doximity ( NYSE:DOCS )
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 30 cents per share.
SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday - Blue Gold ( NASDAQ:BGL ) , Astrana Health ( NASDAQ:ASTH )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Friday. Shares of SoundHound AI, Inc. SOUN rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates.
Pinterest To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday - Crocs ( NASDAQ:CROX ) , Doximity ( NYSE:DOCS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keefe, Bruyette & Woods raised Block Inc XYZ price target from $80 to $95.
Doximity ( DOCS ) Q1 Revenue Rises 15%
Doximity ( NYSE:DOCS ) , a leading digital platform for medical professionals, released results for Q1 FY2026 on August 7, 2025. The company posted GAAP revenue of $145.9 million, missing analyst expectations of $154.4 million ( GAAP ) by about 5.5%.
Doximity ( DOCS ) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +16.13% and +4.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Pathway's AI-powered clinical reference tool helps doctors answer questions about guidelines, drugs and trials.
Doximity Unusual Options Activity For August 07 - Doximity ( NYSE:DOCS )
Financial giants have made a conspicuous bullish move on Doximity. Our analysis of options history for Doximity DOCS revealed 11 unusual trades. Delving into the details, we found 63% of traders were bullish, while 27% showed bearish tendencies.
Is Doximity Gaining or Losing Market Support? - Doximity ( NYSE:DOCS )
Doximity's DOCS short percent of float has fallen 13.66% since its last report. The company recently reported that it has 4.97 million shares sold short, which is 3.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.02 days to cover ...
Claritev Corporation ( CTEV ) Q2 Earnings and Revenues Surpass Estimates
Claritev Corporation (CTEV) delivered earnings and revenue surprises of +111.90% and +4.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health, Inc. ( HIMS ) Misses Q2 Earnings and Revenue Estimates
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
These top telehealth stocks look like smart growth plays right now.
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
HIMS is transforming digital healthcare with AI-driven care, a booming subscriber base, and new tech leadership.
Doximity ( DOCS ) Reports Next Week: Wall Street Expects Earnings Growth
Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
OPRX's subscription shift, DAAP platform, and HCP-DTC reach suggest a moat is forming-but is it built to last?
OMCL vs. DOCS: Which Stock Is the Better Value Option?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell ( OMCL Quick QuoteOMCL - ) and Doximity ( DOCS Quick QuoteDOCS - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing market with new free offering.
Doximity ( DOCS ) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Doximity (DOCS) closed at $59.7, marking a -2.13% move from the previous day.
